86 Pfizer documents show they paid the FDA a $2.8 Million “application fee” for priority review of their COMIRNATY BLA licensing (t.me) posted 2 years ago by interesting_views 2 years ago by interesting_views +86 / -0 4 comments share 4 comments share save hide report block hide replies
So Pfizer paid $2.875 Million to prioritize the FDA application for Comirnaty... and then never made it available in the U.S.?
Why expedite a drug that you don't intend to distribute?
That’s pretty obvious. It was a bribe and Pfizer keeps going without worrying about liability from the EUA version. Of course they would drag their feet to make it available.